Literature DB >> 25543979

Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications.

Prasopchai Tonglairoum1, Tanasait Ngawhirunpat1, Theerasak Rojanarata1, Ruchadaporn Kaomongkolgit2, Praneet Opanasopit3.   

Abstract

Clotrimazole (CZ)-loaded microemulsion-containing nanofiber mats were developed as an alternative for oral candidiasis applications. The microemulsion was composed of oleic acid (O), Tween 80 (T80), and a co-surfactant such as benzyl alcohol (BzOH), ethyl alcohol (EtOH) or isopropyl alcohol (IPA). The nanofiber mats were obtained by electrospinning a blended solution of a CZ-loaded microemulsion and a mixed polymer solution of 2% (w/v) chitosan (CS) and 10% (w/v) polyvinyl alcohol (PVA) at a weight ratio of 30:70. The nanofiber mats were characterized using various analytical techniques. The entrapment efficiency, drug release, antifungal activity and cytotoxicity were investigated. The average diameter of the nanofiber mats was in the range of 105.91-125.56 nm. The differential scanning calorimetry (DSC) and powder X-ray diffractometry (PXRD) results revealed the amorphous state of the CZ-loaded microemulsions incorporated into the nanofiber mats. The entrapment efficiency of CZ in the mats was approximately 72.58-98.10%, depended on the microemulsion formulation. The release experiment demonstrated different CZ release characteristics from nanofiber mats prepared using different CZ-loaded microemulsions. The extent of drug release from the fiber mats at 4h was approximately 64.81-74.15%. The release kinetics appeared to follow Higuchi's model. In comparison with CZ lozenges (10mg), the nanofiber mats exhibited more rapid killing activity. Moreover, the nanofiber mats demonstrated desirable mucoadhesive properties and were safe for 2h. Therefore, the nanofiber mats have the potential to be promising candidates for oral candidiasis applications.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Clotrimazole; Microemulsion; Nanofibers; Oral candidiasis

Mesh:

Substances:

Year:  2014        PMID: 25543979     DOI: 10.1016/j.colsurfb.2014.12.009

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

Review 1.  Trends in polymeric electrospun fibers and their use as oral biomaterials.

Authors:  Agnes B Meireles; Daniella K Corrêa; João Vw da Silveira; Ana Lg Millás; Edison Bittencourt; Gustavo Ea de Brito-Melo; Libardo A González-Torres
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

Review 2.  Application of electrospun fibers for female reproductive health.

Authors:  Anna K Blakney; Yonghou Jiang; Kim A Woodrow
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

3.  Medium-Chain Fatty Acids Released from Polymeric Electrospun Patches Inhibit Candida albicans Growth and Reduce the Biofilm Viability.

Authors:  Katharina H Clitherow; Tahani M Binaljadm; Jens Hansen; Sebastian G Spain; Paul V Hatton; Craig Murdoch
Journal:  ACS Biomater Sci Eng       Date:  2020-05-20

4.  Fabrication and characterization of tretinoin-loaded nanofiber for topical skin delivery.

Authors:  Saba Khoshbakht; Farzin Asghari-Sana; Anahita Fathi-Azarbayjani; Yaeghob Sharifi
Journal:  Biomater Res       Date:  2020-03-02

Review 5.  Molecular Mapping of Antifungal Mechanisms Accessing Biomaterials and New Agents to Target Oral Candidiasis.

Authors:  Valentina Anuța; Marina-Theodora Talianu; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Răzvan Mihai Prisada; Mădălina Georgiana Albu Kaya; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

6.  Three-dimensional bioprinting of mucoadhesive scaffolds for the treatment of oral mucosal lesions; an in vitro study.

Authors:  Maryam Koopaie; Duha Hayder Mohammad Ali Nassar; Mahvash Shokrolahi
Journal:  3D Print Med       Date:  2022-09-28

Review 7.  Biomaterials for the Prevention of Oral Candidiasis Development.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.